Chewable relief for hayfever in children
Belgium's UCB has been granted approval in the US for the first chewable formulation of an antihistamine designed to make it easier to treat children for hayfever.
Belgium's UCB has been granted approval in the US for the first chewable formulation of an antihistamine designed to make it easier to treat children for hayfever.
A new treatment approach could one day make it possible to reverse the paralysis that can occur after spinal cord injuries, which occur in around 11,000 people in Europe every year.
Microfluidics has launched the first research-scale versions of its patented High-Pressure Multiple Stream Mixer Reactor (MMR), claimed to create uniform particles smaller than anything achieved using current technologies.
As the Interphex 2004 exhibition in New York, US, comes to a close, In-Pharmatechnologist.com takes a look at the crop of new products rolled out in the pharmaceutical manufacturing sector.
Korean company Boo Yoon Tech has been granted a US patent on a polyester resin that can be used to make environmentally-friendly, biodegradable pharmaceutical bottles and blister packs.